drugset / Trial / NCT05364190
Canagliflozin in Patients With Acute Decompansted Heart Failure
Phase 3
Completed
142 enrolled
October 6 University
Cairo University · collabNational Heart Institute, Egypt · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The study aims to investigate the efficacy and safety of the early initiation of canagliflozin treatment in hospitalized heart failure patients with volume overload (warm-wet) who require the use of I.V loop diuretic during the hospitalization period.
Timeline
- Start
- 2022-06-04
- Primary completion
- 2023-12-01
- Completion
- 2024-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CANAGLIFLOZIN ANHYDROUS | Small molecule | 100 mg | — |
| Comparator | Empagliflozin | Small molecule | 10 mg | — |